Cargando…
Fairness as an afterthought: An American perspective on fairness in model developer-clinician user collaborations
Numerous ethics guidelines have been handed down over the last few years on the ethical applications of machine learning models. Virtually every one of them mentions the importance of “fairness” in the development and use of these models. Unfortunately, though, these ethics documents omit providing...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659157/ https://www.ncbi.nlm.nih.gov/pubmed/37983258 http://dx.doi.org/10.1371/journal.pdig.0000386 |
Sumario: | Numerous ethics guidelines have been handed down over the last few years on the ethical applications of machine learning models. Virtually every one of them mentions the importance of “fairness” in the development and use of these models. Unfortunately, though, these ethics documents omit providing a consensually adopted definition or characterization of fairness. As one group of authors observed, these documents treat fairness as an “afterthought” whose importance is undeniable but whose essence seems strikingly elusive. In this essay, which offers a distinctly American treatment of “fairness,” we comment on a number of fairness formulations and on qualitative or statistical methods that have been encouraged to achieve fairness. We argue that none of them, at least from an American moral perspective, provides a one-size-fits-all definition of or methodology for securing fairness that could inform or standardize fairness over the universe of use cases witnessing machine learning applications. Instead, we argue that because fairness comprehensions and applications reflect a vast range of use contexts, model developers and clinician users will need to engage in thoughtful collaborations that examine how fairness should be conceived and operationalized in the use case at issue. Part II of this paper illustrates key moments in these collaborations, especially when inter and intra disagreement occurs among model developer and clinician user groups over whether a model is fair or unfair. We conclude by noting that these collaborations will likely occur over the lifetime of a model if its claim to fairness is to advance beyond “afterthought” status. |
---|